74 related articles for article (PubMed ID: 3647766)
1. Activation mechanism of human urinary prokallikrein using trypsin as a model activator.
Takahashi S; Irie A; Katayama Y; Ito K; Miyake Y
Biochem Int; 1987 Mar; 14(3):467-74. PubMed ID: 3647766
[TBL] [Abstract][Full Text] [Related]
2. Human urinary prokallikrein: rapid purification and model activation by trypsin.
Irie A; Takahashi S; Katayama Y; Ito K; Miyake Y
Biochem Int; 1986 Aug; 13(2):375-82. PubMed ID: 3639740
[TBL] [Abstract][Full Text] [Related]
3. Amino acid sequence of a ferredoxin from Bumilleriopsis filiformis, a yellow-green alga: relationship with red algae, protoflorideophyceae, and filamentous blue-green algae.
Inoue K; Hase T; Böger P; Matsubara H
J Biochem; 1983 Nov; 94(5):1451-5. PubMed ID: 6418731
[TBL] [Abstract][Full Text] [Related]
4. Conversion of rat urinary prokallikrein to its active form.
Takenobu Y; Takaoka M; Suyama E; Yano M; Morimoto S
Biochem Int; 1990; 21(3):417-23. PubMed ID: 2222489
[TBL] [Abstract][Full Text] [Related]
5. Complete covalent structure of human platelet factor 4.
Morgan FJ; Begg GS; Chesterman CN
Thromb Haemost; 1980 Feb; 42(5):1652-60. PubMed ID: 6445090
[TBL] [Abstract][Full Text] [Related]
6. Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin.
Takada Y; Skidgel RA; Erdös EG
Biochem J; 1985 Dec; 232(3):851-8. PubMed ID: 3937523
[TBL] [Abstract][Full Text] [Related]
7. Primary structure of human urinary prokallikrein.
Takahashi S; Irie A; Miyake Y
J Biochem; 1988 Jul; 104(1):22-9. PubMed ID: 3065335
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of human tissue kallikrein produced in Escherichia coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein.
Lu HS; Hsu YR; Lu LI; Ruff D; Lyons D; Lin FK
Protein Expr Purif; 1996 Sep; 8(2):215-26. PubMed ID: 8812865
[TBL] [Abstract][Full Text] [Related]
9. Human urinary prokallikrein--structural analysis on activation mechanism.
Takahashi S; Irie A; Katayama Y; Miyake Y
Adv Exp Med Biol; 1989; 247A():513-8. PubMed ID: 2603816
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of human tissue prokallikrein and kallikrein isoforms expressed in Chinese hamster ovary cells.
Lu HS; Hsu YR; Narhi LO; Karkare S; Lin FK
Protein Expr Purif; 1996 Sep; 8(2):227-37. PubMed ID: 8812867
[TBL] [Abstract][Full Text] [Related]
11. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
12. [Amino acid sequence of various tryptic peptides of the envelope protein of the tick-borne encephalitis virus].
Baram GI; Grachev MA; Nazimov IV; Pletnev AG; Pressman EK
Bioorg Khim; 1985 Dec; 11(12):1677-80. PubMed ID: 4084324
[TBL] [Abstract][Full Text] [Related]
13. Monkey pepsinogens and pepsins. IV. The amino acid sequence of the activation peptide segment of Japanese monkey pepsinogen.
Kageyama T; Takahashi K
J Biochem; 1980 Jul; 88(1):9-16. PubMed ID: 6773933
[TBL] [Abstract][Full Text] [Related]
14. N-terminal amino acid sequence of human urinary prokallikrein.
Takahashi S; Irie A; Katayama Y; Ito K; Miyake Y
J Biochem; 1986 Mar; 99(3):989-92. PubMed ID: 3635530
[TBL] [Abstract][Full Text] [Related]
15. An improved method of isolation of rat pancreatic prokallikrein. Characterization of the zymogen and of the kallikrein produced by trypsin activation.
Hussain M; Bailey GS
Biochim Biophys Acta; 1982 Oct; 719(1):40-6. PubMed ID: 6924592
[TBL] [Abstract][Full Text] [Related]
16. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
[TBL] [Abstract][Full Text] [Related]
17. Prokallikrein and kallikrein inhibitors in human urine.
Madeddu P; Oppes M; Rubattu S; Tonolo GC; Dessì-Fulgheri P; Glorioso N; Rappelli A
J Hypertens Suppl; 1985 Dec; 3(3):S283-6. PubMed ID: 2856718
[TBL] [Abstract][Full Text] [Related]
18. Existence of prokallikrein in the kidney. Its biochemical properties compared to three active glandular kallikreins from the kidney, serum, and urine of the rat.
Nishimura K; Shimizu H; Kokubu T
Hypertension; 1983; 5(2):205-10. PubMed ID: 6550028
[TBL] [Abstract][Full Text] [Related]
19. Purification and structural characterization of insulin and glucagon from the bichir Polypterus senegalis (Actinopterygii: Polypteriformes).
Conlon JM; Fan H; Fritzsch B
Gen Comp Endocrinol; 1998 Jan; 109(1):86-93. PubMed ID: 9446726
[TBL] [Abstract][Full Text] [Related]
20. Tryptase and kinin generation: tryptase from human mast cells does not activate human urinary prokallikrein.
Alter SC; Yates P; Margolius HS; Schwartz LB
Int Arch Allergy Appl Immunol; 1987; 83(3):321-4. PubMed ID: 3298074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
